Finance

Lists
Why is EVFM down 6,67%?
Dive Deeper
EVFM:OTCMKTS
Evofem Biosciences Inc
0,0070 USD
-6,67%
(-0,00050) 1D
13-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVFM...
Open
0,01 USD
High
0,01 USD
Low
0,01 USD
Mkt. cap
695,79 миң
Avg. vol.
113,64 миң
Volume
34,28 миң
52-wk high
0,02 USD
52-wk low
0,00 USD
EPS
-0,14 USD
Beta
-1,37
Shares outstanding
132,53 млн
No. of employees
29
Open
0,01 USD
High
0,01 USD
Low
0,01 USD
Mkt. cap
695,79 миң
Avg. vol.
113,64 миң
Volume
34,28 миң
52-wk high
0,02 USD
52-wk low
0,00 USD
EPS
-0,14 USD
Beta
-1,37
Shares outstanding
132,53 млн
No. of employees
29
News stories
From web sources and news partners
About Evofem Biosciences Inc
CEOSaundra Pelletier
Employees29
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteevofem.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,95 млн
9,56 млн
899,00 миң
2,63 млн
Cost of goods sold
905,00 миң
2,59 млн
410,00 миң
511,00 миң
Cost of revenue
905,00 миң
2,59 млн
410,00 миң
511,00 миң
Research and development expenses
469,00 миң
372,00 миң
517,00 миң
693,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,48 млн
3,16 млн
4,47 млн
3,90 млн
Operating expense
5,03 млн
3,62 млн
5,06 млн
4,61 млн
Total operating expenses
5,93 млн
6,22 млн
5,47 млн
5,12 млн
Operating income
-982,00 миң
3,34 млн
-4,57 млн
-2,49 млн
Other non operating income
-2,53 млн
2,08 млн
-162,00 миң
-5,76 млн
EBT including unusual items
-1,57 млн
2,79 млн
-5,47 млн
-11,04 млн
EBT excluding unusual items
-3,51 млн
2,79 млн
-5,47 млн
-8,84 млн
Income tax expense
-4,00 миң
-1,00 миң
-1,00 миң
-
Effective tax rate
0,25%
-0,04%
0,02%
-
Other operating expenses
-
-
-
-
Net income
-1,57 млн
2,79 млн
-5,46 млн
-11,04 млн
Net profit margin
-31,68%
29,16%
-607,90%
-419,14%
Earnings per share
-
-
-
-
Interest and investment income
3,00 миң
2,00 миң
2,00 миң
3,00 миң
Interest expense
-
-2,64 млн
-737,00 миң
-600,00 миң
Net interest expenses
3,00 миң
-2,63 млн
-735,00 миң
-597,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-898,00 миң
3,44 млн
-4,49 млн
-2,47 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору